Athira Pharma raises $85 million in Series B round
The Seattle-based company is one of several that have raised venture capital and equity investment funding this week.
Dascena raises $50M in Series B round, publishes data on machine learning in sepsis prediction
A round-up of funding announcements this week. Other companies that have raised new venture capital funding rounds this week include Genespire, HeartVista and Particle Health and Vida.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
RDMD raises $14M for rare disease real-world evidence generation
The San Francisco-based startup is one of several that have been raising money over the past couple of weeks in areas like neurology, oncology and women's health.
Paris conference aims to put European biotech on the map
The first HealthTech Investor Days conference takes place Monday and Tuesday. The event will bring together 100 late-stage companies with investors, pharma companies and others.
MedDay raises $38.5M to kick off U.S. clinical trials for multiple sclerosis
MedDay's new spate of U.S. trials follow the successful Phase 3 study in progressive multiple sclerosis in Europe.
Sofinnova Partners launches a €300M biotech startup fund with European focus
The venture capital firm, looking to further expand its life sciences portfolio, has now brought the total amount under management to €1.5 billion ($1.6 billion).
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.